LanzaTech NZ, Inc.
8Patents
8Active
8Granted
41Portfolio score
Filing activity: Feb 26, 2017 → Sep 27, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11549103B2 | Recombinant microorganisms and methods of use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11965201B2 | Arginine supplementation to improve efficiency in gas fermenting acetogens | Emerging Cross-Sectional Technologies | 0 | Active |
| US11653672B2 | Gas fermentation for the production of protein or feed | Emerging Cross-Sectional Technologies | 0 | Active |
| US11753612B2 | Control of bioreactor processes | Emerging Cross-Sectional Technologies | 0 | Active |
| US11459589B2 | Microbial fermentation for the production of terpenes | Emerging Cross-Sectional Technologies | 0 | Active |
| US11441149B2 | CRISPR/cas systems for c1-fixing bacteria | Emerging Cross-Sectional Technologies | 0 | Active |
| US11814666B2 | Gas testing unit and method | Emerging Cross-Sectional Technologies | 0 | Active |
| US11618910B2 | Methods and systems for the production of alcohols and/or acids | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.